Role of Metabolic Stress and Exercise in Regulating Fibro/Adipogenic Progenitors
Nicolas Collao1 
Michael De Lisio- 1School of Human Kinetics, University of Ottawa, Ottawa, ON, Canada
- 2Department of Biomedicine, Aarhus University, Aarhus, Denmark
- 3Department of Cellular and Molecular Medicine, Centre for Neuromuscular Disease, University of Ottawa, Ottawa, ON, Canada
Obesity is a major public health concern and is associated with decreased muscle quality (i.e., strength, metabolism). Muscle from obese adults is characterized by increases in fatty, fibrotic tissue that decreases the force producing capacity of muscle and impairs glucose disposal. Fibro/adipogenic progenitors (FAPs) are muscle resident, multipotent stromal cells that are responsible for muscle fibro/fatty tissue accumulation. Additionally, they are indirectly involved in muscle adaptation through their promotion of myogenic (muscle-forming) satellite cell proliferation and differentiation. In conditions similar to obesity that are characterized by chronic muscle degeneration, FAP dysfunction has been shown to be responsible for increased fibro/fatty tissue accumulation in skeletal muscle, and impaired satellite cell function. The role of metabolic stress in regulating FAP differentiation and paracrine function in skeletal muscle is just beginning to be unraveled. Thus, the present review aims to summarize the recent literature on the role of metabolic stress in regulating FAP differentiation and paracrine function in skeletal muscle, and the mechanisms responsible for these effects. Furthermore, we will review the role of physical activity in reversing or ameliorating the detrimental effects of obesity on FAP function.
Introduction
Over the last decades, lifestyle changes in western societies such as diet and physical inactivity are a major global public health problem leading to metabolic syndrome (MetS) (Saklayen, 2018). MetS is a cluster of different conditions including central adiposity, hypertension, insulin resistance, inflammation, and dyslipidemias, among others, which are themselves risk factors for type 2 diabetes (T2D), cardiovascular disease and even increasing the risk of cancer (Manuel et al., 2014). According to the World Health Organization (WHO), obesity (body mass index (BMI) ≥ 30 kg/m2) has almost tripled since 1975, such that as of 2016 over 603 million adults and 107 million children are obese (WHO, 2019). This increased incidence of MetS is associated with an increase in the prevalence of musculoskeletal diseases and disorders (Wearing et al., 2006; Collins et al., 2018). Emerging evidence has shown that metabolic complications are positively correlated to reduction of muscle mass, impaired muscle repair, and increase in fibro/fatty tissue accumulation (Akhmedov and Berdeaux, 2013). These pathological changes ultimately result in increased morbidity and disability (Hoy et al., 2014; March et al., 2014).
Underlying these pathological changes are alterations in the heterogeneous stem/progenitor cell populations that reside within skeletal muscle. The regenerative potential of skeletal muscle relies primarily on myogenic stem cells, called satellite cells (MuSCs), residing under the myofiber basal lamina (Wang and Rudnicki, 2011; Bentzinger et al., 2013). Upon muscle injury MuSCs enter the cell cycle, proliferate, and differentiate to repair damaged myofibers, while self-renewing to repopulate the reserve pool (Feige et al., 2018). Recently, a novel mesenchymal cell population of non-myogenic cells, named fibro/adipogenic progenitors (FAPs), has been identified in the skeletal muscle interstitium (Joe et al., 2010; Uezumi et al., 2010). FAPs are critical during muscle regeneration in order to sustain MuSC differentiation via paracrine mechanisms, and to maintain the MuSCs pool (Wosczyna et al., 2019). However, in pathological conditions FAP expansion continues unchecked, resulting in the production of fibro/fatty infiltrations, and impaired myogenesis (Rodeheffer, 2010; Uezumi et al., 2010, 2011; Mozzetta et al., 2013; Dong et al., 2017; Madaro et al., 2018; Stumm et al., 2018). Metabolism plays a crucial role in controlling the fate of progenitor cells, including MuSCs in tissue development, homeostasis, regeneration, and disease (Ryall et al., 2015a; Knobloch et al., 2017; Pala et al., 2018); however, the effects of metabolic stress and the metabolic regulation of FAPs has only recently begun to be explored. As such, the purpose of the present review is to provide an overview of the current state of the literature regarding to the effects of metabolic stress, induced by disease or exercise, on FAP differentiation and paracrine function.
Connection Between Metabolic Stress and Ectopic Adipose Tissue Accumulation in Muscle
Skeletal muscle is an important tissue for the regulation of whole-body metabolic homeostasis. In most individuals, skeletal muscle comprises 40–60% of the total body mass, accounts for ∼30% of the resting metabolic rate in adult humans (Zurlo et al., 1990), is a key contributor to whole body lipid utilization (Egan and Zierath, 2013), and ∼80% insulin-stimulated glucose disposal (Brüning et al., 1998). Skeletal muscle has a high capacity for substrate oxidation and a relatively high potential for substrate storage (DeFronzo et al., 1981). Under conditions of metabolic stress, detrimental changes to skeletal muscle occur, including muscle loss, intra- and inter-myofibrillar lipid accumulation, and connective tissue deposition. Eventually, these changes lead to a detrimental effect on contractile function and/or metabolic properties of skeletal muscle having an important impact on human health and contribute to insulin resistance (Sakuma and Yamaguchi, 2013). In the obese state, muscle lipid accumulation may occur as a result of insufficient adipose tissue expansion, in which the excess lipid are stored in non-adipose tissue compartments such as liver and skeletal muscle (Szendroedi et al., 2014; Cuthbertson et al., 2017; Czech, 2017; Conte et al., 2019). One result of the ectopic adipose tissue accumulation is the expansion of intramyocellular lipids (IMCLs) located within muscle cells (Sinha et al., 2002; Boesch et al., 2006). Paradoxically, endurance trained individuals also demonstrate an accumulation of IMCLs that are distinguished from the obese state by their location (Samjoo et al., 2013). Whereas in athletes IMCLs provide a local store of substrate for aerobic ATP generation, in persons with obesity, IMCLs are linked to insulin resistance and increased risk of T2D (Kautzky-Willer et al., 2003; Brumbaugh et al., 2012).
Intermuscular adipose tissue is distinguished from IMCLs as the former represents adipocytes that form between muscle fibers and muscle groups (Hamrick et al., 2016). Intermuscular adipose tissue increase with age in humans (Kirkland et al., 2002; Addison et al., 2014) and is highly correlated with a decrease in muscle mass, muscle strength, and insulin-sensitivity (Visser et al., 2005; Miljkovic-Gacic et al., 2008; Delmonico et al., 2009). Similarly, in participants with obesity, intermuscular adipose tissue accumulates and is associated with systemic insulin resistance (Goodpaster et al., 2000; Goss and Gower, 2012). Although not yet directly tested, the local accumulation of intermuscular adipose tissue may impair muscle metabolism by producing high intramuscular concentrations of adipokines, adipose-derived hormones, and free fatty acids. In support of this notion, some studies have reported positive correlations between intermuscular adipose tissue accumulation and the decrease in insulin sensitivity observed during aging and obesity (Goodpaster et al., 1997, 2000; Ryan and Nicklas, 1999; Sachs et al., 2019). Interestingly, the majority of studies on intermuscular adipose tissue accumulation under conditions of metabolic stress have been conducted in humans. Three recent studies indicated that intermuscular adipose tissue accumulates in rodents in both obesity (Khan et al., 2015; Zhu et al., 2019) and aging (Cui et al., 2019). This is relevant because most of the work investigating the mechanisms regulating intermuscular tissue adipose tissue accumulation have been conducted in rodents. Thus, similar responses in human and rodent skeletal muscle have been observed in the limited studies that have evaluated intermuscular adipose tissue accumulation in metabolic stress.
Fibro/Adipogenic Progenitors as the Cellular Source of Intermuscular Adipose Tissue
Fibro/adipogenic progenitors are muscle-resident non-myogenic progenitors of mesenchymal origin, which express stem cell antigen 1 (Sca-1), platelet-derived growth factor receptor α (PDGFRα), and also high levels of CD34 (Joe et al., 2010; Uezumi et al., 2010, 2014). FAPs are distinct from MuSCs as they lack Pax7 expression (Joe et al., 2010; Uezumi et al., 2010, 2014). FAPs have been defined as multi-potent progenitors, residing on the abluminal side of the capillaries in the interstitial spaces between the myofibers in both humans and mouse skeletal muscle (Joe et al., 2010; Uezumi et al., 2010; Arrighi et al., 2015). These cells are defined by their ability to differentiate into fibroblasts, adipocytes, and osteoblasts, and originate from a non-myogenic (Myf5-) cell population which is supported by their lack of myotube formation in vitro (Joe et al., 2010; Uezumi et al., 2010). Following muscle injury, FAPs transiently become activated, proliferated, and expand (Lemos et al., 2015; Wosczyna et al., 2019). Via primarily paracrine mechanisms, FAPs promote MuSC proliferation (Fiore et al., 2016) and differentiation (Joe et al., 2010; De Lisio et al., 2014; Zou et al., 2015; Contreras et al., 2016; Dammone et al., 2018; Madaro et al., 2018), thus participating in muscle repair. Conversely, in pathological conditions characterized by myofiber damage or atrophy, FAPs undergo unchecked expansion and differentiation causing fibrosis, fat deposition an impaired myogenesis (Lemos et al., 2015; Dammone et al., 2018; Madaro et al., 2018).
Metabolic stress has been linked to FAP accumulation and fibro/adipogenic differentiation (Dammone et al., 2018; Gorski et al., 2018; Kang et al., 2018; Buras et al., 2019). Using several different genetic and diet-induced mouse models of diabetes, Mogi et al. (2016) demonstrated that ectopic adipocyte accumulation in skeletal muscle was derived from PDGFRα+ progenitors. Similarly, Arrighi et al. (2015) isolated a population of FAPs, identified as CD56–CD15+/PDGFRα+, that formed functional adipocytes in vitro. These FAP-derived adipocytes may have reduced insulin sensitivity compared to conventional adipocytes, as indicated by lack of phosphorylation of insulin receptor, suggesting that accumulation of FAP-derived adipocytes may contribute to a compromised peripheral insulin sensitivity (Arrighi et al., 2015). However, given the relatively small contribution of intermuscular adipose tissue relative to whole body adipose depots, the negative effects of intermuscular adipose tissue on glucose disposal is likely via secondary mechanisms that reduce the ability of myofibers to uptake glucose. Similar to findings in limb skeletal muscle, 6 months of high-fat feeding induced FAP proliferation, increased adipocytes, and type I collagen-depositing fibroblasts in the diaphragm leading to respiratory dysfunction (Buras et al., 2019). Together, these data indicate that in obesity and related metabolic disorders, FAPs directly contribute to intermuscular adipose tissue accumulation in skeletal muscle.
Several potential mediators of the effects of obesity on FAP differentiation have been investigated. Adipokines released from expanded adipose tissue such as thrombospondin 1 (THBS1), was increased in obese mice and promoted FAP proliferation (Buras et al., 2019). Similarly, TGFβ which is produced in many organs including adipose tissue (Lee, 2018) controls FAP proliferation and differentiation to a fibrogenic lineage in vitro (Ito et al., 2013; Lemos et al., 2015). Conversely, inhibition of PDGFRα and TGFβ signaling resulted in reduced FAP number and a reduction in collagen deposition (Ieronimakis et al., 2013; Ito et al., 2013; Lemos et al., 2015; Fiore et al., 2016). Thus, several adipocyte-derive factors increase FAP adipogenesis, indicating a direct mechanism whereby adipose tissue expansion in obesity may stimulate intermuscular adipose tissue accumulation.
In contrast to adipokines, factors synthesized by myofibers play an important role in limiting adipogenesis during muscle regeneration. Nitric oxide (NO), which is increased in response to muscle injury and exercise, inhibits FAP adipogenic differentiation by down-regulation of the peroxisome proliferator-activated receptors gamma (PPARg) (Cordani et al., 2014). Marinkovic et al. (2019) showed that suppression of myofiber-derived NOTCH signaling via inhibition of γ-secretase or by interfering with the expression of NOTCH stimulates FAP differentiation in a dose-dependent manner, whereas activation by the NOTCH ligand DLL1 leads to significant inhibition of adipogenesis in mdx mice. Kopinke et al. (2017) demonstrated a critical role of cilia in modulating the adipogenic fate of FAPs by controlling the activity of the Hedgehog signaling pathway. Pharmacological inhibition of matrix metalloprotease (MMP)-14 represses C/EBPδ and PPARγ in FAPs by way of cilia Hedgehog signaling and this reduces the adipogenic fate of FAPs. As a result, this enhanced muscle regeneration during acute muscular injury and in a model of muscular dystrophy (Kopinke et al., 2017). Collectively, these data indicate that regenerating muscle releases several factors that inhibit FAP adipogenesis, providing a potential mechanism whereby exercise-induced muscle damage may prevent ectopic intermuscular adipose tissue accumulation under metabolic stress.
Cell metabolism is also a driver of mesenchymal progenitor cell fate during differentiation. For instance, during induction of adipogenesis mesenchymal progenitors need to enhance reliance on oxidative phosphorylation in order to continue differentiation into pre- and mature adipocytes (Shyh-Chang et al., 2013). This may explain why incubating fibroblasts from human skeletal muscle with fatty acids is a potent inducer of adipogenesis (Agley et al., 2013). Similarly, generation of osteoblasts is also associated with high reliance on oxidative phosphorylation. In contrast, fibrogenesis and chondrogenesis seems to require utilization of glycolysis during differentiation (Shyh-Chang et al., 2013; Zhao et al., 2019). FAPs from regenerating mdx muscle have an increase in glycolytic proteins and a reduction of mitochondrial proteins compared to control mice (Marinkovic et al., 2019) resulting in mdx FAPs favoring glycolysis over oxidative metabolism (Reggio et al., 2019). Interestingly, these metabolic changes were associated with greater proliferative capacity and adipogenic potential in vitro which was reversed by inhibiting glycolysis and forcing oxidative metabolism (Reggio et al., 2019). This impaired metabolic phenotype was reversed in vivo by providing a short-term high fat diet which stimulated oxidative metabolism in FAPs (Reggio et al., 2019). Conversely, long-term high fat diet, and obesity are associated with increased muscle adiposity and fibrosis (Goodpaster et al., 2000). Hogarth et al. (2019) identify FAPs and their adipogenic differentiation as a major contributor to dysferlin-deficient muscle loss in limb-girdle muscular dystrophy 2B (LGMD2B); a disease associated with mitochondrial dysfunction (Vincent et al., 2016). Together, these interesting findings indicate that mitochondrial function and metabolism are important regulators of FAP fate, and that the FAP response to metabolic stress may be distinct from other interstitial cells in skeletal muscle or from mesenchymal cells in different tissues. Further, they suggest that FAP fate may be regulated by substrate availability, which provides novel areas for therapy.
The effects of exercise on FAP differentiation have yet to be fully elucidated. Endurance exercise training is associated with an increase in IMCLs, but not intermuscular adipose tissue (van Loon et al., 2004; Dubé et al., 2008). Furthermore, acute resistance and endurance exercise is known to increase muscle extracellular matrix synthesis with a similar increase in breakdown resulting in matrix remodeling without excessive accumulation, unlike pathological conditions (Martinez-Huenchullan et al., 2017). Using a preclinical model of radiation exposure, recent work from our group showed a differential FAP response of obese and exercise trained mice (D’Souza et al., 2019). Interestingly muscle fibrosis and adipose tissue accumulation were higher in high fat-fed mice with no effect of treadmill exercise. However, we were not able to distinguish between intermuscular and intramyocellular adipose tissue in our analyses. Conversely, FAP content trended to increase in high fat-fed, sedentary mice, and trended to be reduced in high fat-fed, exercise trained mice (D’Souza et al., 2019). While these results are preliminary, they suggest that exercise training may inhibit FAP expansion in obesity. Similarly, Zeve et al. (2016) reported that endurance exercise suppressed adipogenic progenitor proliferation and differentiation into mature adipocytes in vitro and suppressed adipogenesis in vivo in mice fed a high fat diet. These effects were mediated in part through secretion of R-spondin 3 from slow myofibers, which may activate Wnt signaling to suppress adipogenesis (Zeve et al., 2016). In the bone marrow, exercise training and mechanical forces inhibit adipogenic differentiation of mesenchymal stromal cells (Emmons et al., 2017; Rubin et al., 2018), a population similar to skeletal muscle FAPs. Future work should investigate if similar effects of exercise are present in skeletal muscle FAPs. Under conditions of metabolic stress, exercise may directly regulate oxidative capacity of FAPs by stimulating mitochondrial biogenesis as it does in skeletal muscle, or counteract the pro-adipogenic effects of adipokines by increasing secretion of anti-adipogenic factors from myofibers.
The Relationship Between Metabolic Stress and the Fap Secretome
Fibro/adipogenic progenitors exert much of their functional effects on muscle regeneration and repair via responding to and secreting paracrine factors in their local microenvironment (Joe et al., 2010; Lemos et al., 2015). The most complete list of factors that are secreted by FAPs, and that FAPs respond to have been reviewed elsewhere (Biferali et al., 2019). Interestingly, despite the importance of paracrine factor signaling on FAP function, relatively little attention has been paid to the role of metabolic stress on the FAP secretome. One myogenic paracrine factor that has received some attention in the literature is follistatin (Mozzetta et al., 2013; Reggio et al., 2019). Follistatin is a myostatin inhibitor, and thus promotes muscle growth (Lee and McPherron, 2001) and glucose uptake (Han et al., 2019). Recent studies determined that FAPs are a major source of follistatin in skeletal muscle, and FAP-derived follistatin is a key mechanism responsible for FAP-induced myoblast differentiation (Mozzetta et al., 2013). Further, HDAC inhibitors blocked adipogenic differentiation of FAPs and improved their ability to promote differentiation of MuSCs, through upregulation of the soluble factor follistatin in early stage, but not late stage, mdx mice; which are also characterized by metabolic defects (Mozzetta et al., 2013). Using the same mdx mouse model of muscular dystrophy, Reggio et al. (2019) demonstrated that follistatin is diminished in FAPs due to reduced β-catenin signaling. However, short-term high fat diet feeding reversed this defect by increasing β-catenin levels which promoted IGF-1 and follistatin expression and release leading to improved ability of FAPs to support myogenesis and muscle regeneration (Reggio et al., 2019). Thus, short-term metabolic reprograming of FAPs, via high fat diet feeding may ameliorate some of the regenerative defects observed in dystrophic mice (Reggio et al., 2019). Similarly, recent work from our laboratory using a model of in vivo radiation exposure demonstrated that high fat feeding increased levels of phosphorylated NF-κB, particularly in interstitial nuclei (D’Souza et al., 2019). However, it was not evident if this marker of increased interstitial NF-κB activation was localized specifically to FAPs (D’Souza et al., 2019). In the context of aging, Lukjanenko et al. (2019) determined that diminished FAP secretion of the matricellular protein WNT1 inducible signaling pathway protein 1 (WISP-1) underlies the impairment in MuSC regenerative capacity. However, in this same study, the authours determined that adipogenic differentiation of FAPs is diminished (Lukjanenko et al., 2019). Thus, the signals regulating FAP function may differ between aging and obesity. These data indicate that in models associated with metabolic dysfunction, short-term high fat feeding, can increase paracrine factor secretions from FAPs, which contrast some of the detrimental effects of long-term high fat feeding on FAP differentiation. Mechanistically, it will be important to determine if the specific composition of the diet is relevant to regulating the FAP secretome, or if alterations in FAP paracrine factor secretion are due to increased adiposity associated with the diet, and what regulates the apparent differential responses of FAP differentiation/secretome to long- versus short-term high fat feeding.
Exercise, and exercise-induced signals, have been suggested to alter FAP paracrine function (Boppart et al., 2013). Exercise used to induce a physiologically relevant adaptive response has been shown to increase FAP content in humans (Farup et al., 2015), and a heterogeneous population of muscle mesenchymal stromal cells which contains FAPs in mice (Valero et al., 2012). In these studies, increased FAP content was associated with increases in MuSCs and an enhanced muscle adaptive response to exercise (Valero et al., 2012; Farup et al., 2015). Using a model of in vitro “exercise” where isolated muscle mesenchymal cells, including FAPs, were exposed to mechanical forces, it was determined that the strained cells produced a mix of paracrine factors that enhanced myoblast proliferation in vitro (De Lisio et al., 2014). Further, mechanical strain applied to these stromal cells in vitro prior to injection into muscle in vivo improved the muscle response to exercise (Huntsman et al., 2013, 2018; Zou et al., 2015). The relative contribution of FAPs to the overall secretome of the heterogeneous population of muscle-derived mesenchymal cells at rest and after exercise remains to be determined.
The Effects of Metabolic Stress on Fap Activation
In relation to obesity and T2D one of the most obvious changes in the systemic environment is the chronically elevated levels of metabolic substrates such as glucose and triglycerides. Activation (exit from quiescence) and first cell division of stem/progenitor cells (e.g., MuSCs or FAPs) has in recent years been described as a highly unique process compared to the following (second, third, etc.) cell divisions (Rodgers et al., 2014; Liu et al., 2018). For instance, in mice time-to-first division in MuSCs is approximately 60 h, whereas the following divisions are approximately four times faster. Although not well-described in FAPs yet, we speculate that the same may be true for FAPs since most of these also reside in a quiescent/non-cycling state in normal mouse muscle (Joe et al., 2010; Rodgers et al., 2014). The time before first cell division is characterized by a major increase in cell size, anabolic signaling, mitochondrial content and ATP levels (Rodgers et al., 2014). In MuSCs these changes have been associated with an increased reliance on glycolysis as well as increased autophagic flux likely to support sufficient generation of ATP and biomass to prepare for the cell cycle (Tang and Rando, 2014; Ryall et al., 2015b). In contrast, genetic deletion of major enzymes involved in this anabolic process (e.g., mTORC1) or blocking autophagy delays the cell cycle entry (Rodgers et al., 2014; Tang and Rando, 2014; Ryall et al., 2015b). Glucose and related insulin signaling are major upstream regulators of these pathways making them likely candidates for perturbing the balance between maintaining and exiting quiescence. Although there is yet no direct evidence linking changes in substrate availability in the FAP niche to activation of FAPs it is interesting to note how the major FAP regulator, platelet-derived growth factor (PDGF), is driving changes in cell metabolism. For instance, PDGF treatment of muscle FAPs leads to increased cell proliferation as well as transcriptional changes related to glycolysis (Mueller et al., 2016). Moreover, PDGF signaling in mesenchymal progenitors or fibroblasts from other tissues is known to increase reliance on glycolysis and thereby also increasing lactate production (Ran et al., 2013; Xiao et al., 2017). In fact, fibrosis in multiple tissues is associated with increased glycolytic flux compared to non-fibrotic areas and blocking glycolysis seems to ameliorate some of these pathological events and reduce extracellular matrix accumulation (Zhao et al., 2019). This suggest that increased glycolysis is not merely a result of cell activation, but likely have a causal relationship to cell activation. Collectively, evidence is accumulating that cell metabolism is intimately involved in fibrosis development, in skeletal muscle potentially through priming FAPs for exiting quiescence. Since the normal FAP clearance (as observed during skeletal muscle regeneration from TNFα induced FAP apoptosis) (Lemos et al., 2015) is likely not present under these circumstance, one can speculate that this could lead FAPs to accumulate over time, contributing to increased fatty-degeneration of the skeletal muscles in obesity and T2D.
Exercise provides a unique, physiological stimulus to examine the role of mechanical and metabolic stress on skeletal muscle that results in efficient and complete repair and adaptation. Early work demonstrated that a single bout of damaging exercise increased the content of a heterogeneous population of muscle-derived mesenchymal progenitors, which likely included FAPs (Valero et al., 2012). These findings mirrored the effects of acute exercise on mesenchymal progenitors in other tissues, such as the bone marrow (Emmons et al., 2016). More recent work has suggested that the effects of exercise might be dependent on the population of mesenchymal progenitors investigated. Muscle pericytes did not increase in human muscle following eccentric exercise (De Lisio et al., 2015) or in mice following electrical stimulation (Dvoretskiy et al., 2019). This response is different from mesenchymal progenitors from other tissues, as bone marrow-derived mesenchymal progenitors are activated by an acute exercise (Emmons et al., 2016). Conversely, resistance training was associated with an increase in the content of FAPs expressing markers of active cell cycle (Farup et al., 2015). As such, the available data suggest that the effects of exercise FAP/mesenchymal progenitor activation may be dependent on the tissue of origin and specifics of the exercise stimulus, among other, yet-to-be investigated factors. Moreover, in mouse and in particular in human skeletal muscle, more in-depth phenotyping is needed in order to distinguish the specific overlapping interstitial cell populations in muscle.
The Role of Chronic Low-Grade Inflammation in Metabolic Stress on Fap Function
The inflammatory response following muscle injury is a well-orchestrated, time-dependent process necessary to obtain complete muscle regeneration (Tidball, 2017). This response begins with the infiltration of the earliest immune cells such as neutrophils and eosinophils (Tidball, 2011). During muscle injury, IL-4 and IL-13-secreting eosinophils are recruited to the injured site (Heredia et al., 2013). These inflammatory signals act through IL-4Rα to stimulate signal transducer of transcription 6 (STAT6), which promotes FAP proliferation and inhibits FAP differentiation into adipocytes (Heredia et al., 2013). The early immune response is followed by an infiltration of macrophages with a M1 phenotype (pro-inflammatory) followed by the expansion of M2 macrophages (anti-inflammatory), which are associated with tissue repair and MuSC differentiation (Chazaud et al., 2003). Therefore, the polarization of M1 and M2 macrophages play a crucial role in successful muscle regeneration. Recently, it has been suggested that in response to acute muscle damage, macrophage-derived TNF-α plays a crucial role in regulating FAP apoptosis (Lemos et al., 2015; Fiore et al., 2016). Indeed, Lemos et al. (2015) demonstrated that in the absence of TNF-α-producing macrophages, FAPs accumulate and aberrantly differentiate into a fibrogenic lineage. Pagano et al. (2019) showed that TNF-α mediated FAP apoptosis might be perturbed in a glycerol model of muscle injury, leading to intermuscular adipose tissue development. However, treatment with the TGF-β inhibitor decorin decreases intermuscular adipose tissue development and might restore FAP apoptosis (Pagano et al., 2019). Thus, inflammatory cell-derived factors are required for proper FAP regulation, and any dysregulation of the timing or concentrations of these factors could contribute to pathological extracellular matrix accumulation by FAPs.
In contrast to the acute inflammatory response to muscle damage, myopathies, dystrophies, aging, diabetes, and obesity are associated with a chronic low-grade inflammation. This chronic, low-grade inflammation is associated impaired function of MuSCs, immune cells, and FAPs, leading to fibrosis, and poor skeletal muscle regeneration (Rostasy et al., 2008; Mann et al., 2011; D’Souza et al., 2015; Wang et al., 2015). Moreover, chronic inflammation in these conditions results in an increase in cytokine release that is responsible for the extracellular matrix production (Van Linthout et al., 2014). Consequently, muscle fibrosis develops which disrupts the cell niche for proper skeletal muscle regeneration (Murphy et al., 2011). Specifically, during chronic muscle damage, macrophage-derived TGF-β1, inhibits TNF-mediated FAP, and instead induce their fibrogenic differentiation and consequent extracellular matrix deposition (Lemos et al., 2015; Davies et al., 2016; Fiore et al., 2016; Juban et al., 2018). Similarly, Moratal et al. (2018) report that IL-1β-activated macrophages and IL-4-polarized macrophages have opposite effects on FAP differentiation into adipocytes in vitro, which was dependent on Smad2 phosphorylation in FAPs. Thus, under chronic inflammatory conditions associated with several metabolic disorders, signals that regulate FAP apoptosis and inhibit proliferation are perturbed, leading to a chronic state of remodeling which ultimately results in fibro/fatty tissue accumulation.
Exercise is a well-known modulator of the inflammatory response (Febbraio, 2007; Lancaster and Febbraio, 2014). In response to acute exercise, skeletal muscle produces a myriad of pro-inflammatory cytokines, including but not limited to IL-6 (Pedersen and Steensberg, 2002), IL-1ra (Ostrowski et al., 1998), IL-8, and IL-15 (Nielsen and Pedersen, 2007). The role of these cytokines in relation to skeletal muscle is to participate in the muscle repair/adaptive response to exercise (Serrano et al., 2008; McKay et al., 2009), and modulate whole-body and muscle glucose metabolism (Febbraio et al., 2004; Carey et al., 2006). Additionally, cellular mediators of the inflammatory response, increase in skeletal muscle after acute exercise (Paulsen et al., 2010), and macrophages with a pro-regenerative phenotype also increase in skeletal muscle following 12 weeks of endurance training (Walton et al., 2019). The increase in phenotypically pro-regenerative macrophages was associated with greater increases in fiber cross-sectional area and increases in MuSC content (Walton et al., 2019). Mesenchymal stromal cells in other tissues are known to regulate inflammatory responses (Munir et al., 2018); however, whether they regulate muscle inflammation, and how exercise can influence this relationship remains unknown.
Perspectives and Conclusion
Obesity, diabetes, and other metabolic disorders are reaching epidemic proportions in western countries. Impairment of skeletal muscle is a central player in the detrimental effects of metabolic stress leading and metabolic disorders. Under conditions of metabolic stress, muscle dysfunction is characterized by excessive intermuscular adipocytes, extracellular matrix accumulation, and inflammation (Lawler et al., 2016). In these conditions, the accumulation of fibro/fatty tissue in skeletal muscle is associated with a loss of muscle mass, a reduction in muscle strength (Delmonico et al., 2009), insulin resistance, and inflammation (Szendroedi et al., 2014). As the cellular source of intermuscular adipose tissue, primary producers of the extracellular matrix, and key regulators of muscle mass, FAPs are central to these detrimental changes in skeletal muscle under metabolic stress (Figure 1). Exercise is an effective first line therapy for metabolic disorders; however, the role of exercise on FAP fate and function are just beginning to be identified. As the effects of metabolic stress and role of metabolism in regulating FAP function begin to be unraveled in the coming years, as well as the mechanisms responsible for exercise-induced FAP regulation, novel avenues for therapy will emerge to maintain muscle function, metabolic health, and reduce morbidity.
Figure 1. The influence of metabolic stress on fibro/adipogenic progenitor (FAPs) cell function. In skeletal muscle, metabolic stress leads to an accumulation of intermuscular adipose tissue, extracellular matrix production, and inflammation. FAPs are the primary cellular source of intermuscular adipose tissue, extracellular matrix proteins, and interact with immune cells to participate in the inflammatory response. Available literature indicates that during metabolic stress FAPs favor glycolysis during proliferation and adipogenic differentiation, and downregulate the production of the pro-myogenic factor follistatin (fst) via modulation of the β-catenin signaling pathway. In aging, altered secretion of WNT1 inducible signaling pathway protein 1 (WISP1) by FAPs, which may be induced by mitochondrial dysfunction, reduces their capacity to support MuSC activation and commitment. Exercise reduces the characteristic changes in skeletal muscle that occur during metabolic stress. Further, exercise stimulates FAP production of pro-myogenic factors and may inhibit adipogenic and fibrogenic potential of FAPs.
Author Contributions
NC and MD conceived the topic for review. NC, JF, and MD wrote the review.
Funding
This work was supported by grants from the National Sciences and Engineering Research Council (NSERC), and the American Institute for Cancer Research (AICR) to MD. NC is the recipient of the CONICYT-CHILE Doctoral Research Award and the Doctoral Fellowship for Advancement of Biological Perspectives for Exercise Interventions Across the Lifespan.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
Addison, O., Marcus, R. L., Lastayo, P. C., and Ryan, A. S. (2014). Intermuscular fat: a review of the consequences and causes. Int. J. Endocrinol. 2014:309570. doi: 10.1155/2014/309570
Agley, C. C., Rowlerson, A. M., Velloso, C. P., Lazarus, N. R., and Harridge, S. D. R. (2013). Human skeletal muscle fibroblasts, but not myogenic cells, readily undergo adipogenic differentiation. J. Cell Sci. 126, 5610–5625. doi: 10.1242/jcs.132563
Akhmedov, D., and Berdeaux, R. (2013). The effects of obesity on skeletal muscle regeneration. Front. Physiol. 4:371. doi: 10.3389/fphys.2013.00371
Arrighi, N., Moratal, C., Clément, N., Giorgetti-Peraldi, S., Peraldi, P., Loubat, A., et al. (2015). Characterization of adipocytes derived from fibro/adipogenic progenitors resident in human skeletal muscle. Cell Death Dis. 6:e1733. doi: 10.1038/cddis.2015.79
Bentzinger, C. F., Wang, Y. X., Dumont, N. A., and Rudnicki, M. A. (2013). Cellular dynamics in the muscle satellite cell niche. EMBO Rep. 14, 1062–1072. doi: 10.1038/embor.2013.182
Biferali, B., Proietti, D., Mozzetta, C., and Madaro, L. (2019). Fibro–adipogenic progenitors cross-talk in skeletal muscle: the social network. Front. Physiol. 10:1074. doi: 10.3389/fphys.2019.01074
Boesch, C., Machann, J., Vermathen, P., and Schick, F. (2006). Role of proton MR for the study of muscle lipid metabolism. NMR Biomed. 19, 968–988. doi: 10.1002/nbm.1096
Boppart, M. D., De Lisio, M., Zou, K., and Huntsman, H. D. (2013). Defining a role for non-satellite stem cells in the regulation of muscle repair following exercise. Front. Physiol. 4:310. doi: 10.3389/fphys.2013.00310
Brumbaugh, D. E., Crume, T. L., Nadeau, K., Scherzinger, A., and Dabelea, D. (2012). Intramyocellular lipid is associated with visceral adiposity, markers of insulin resistance, and cardiovascular risk in prepubertal children: the EPOCH study. J. Clin. Endocrinol. Metab. 97, E1099–E1105. doi: 10.1210/jc.2011-3243
Brüning, J. C., Michael, M. D., Winnay, J. N., Hayashi, T., Hörsch, D., Accili, D., et al. (1998). A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell 2, 559–569. doi: 10.1016/s1097-2765(00)80155-0
Buras, E. D., Converso-Baran, K., Davis, C. S., Akama, T., Hikage, F., Michele, D. E., et al. (2019). Fibro-adipogenic remodeling of the diaphragm in obesity-associated respiratory dysfunction. Diabetes 68, 45–56. doi: 10.2337/db18-0209
Carey, A. L., Steinberg, G. R., Macaulay, S. L., Thomas, W. G., Holmes, A. G., Ramm, G., et al. (2006). Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 55, 2688–2697. doi: 10.2337/db05-1404
Chazaud, B., Sonnet, C., Lafuste, P., Bassez, G., Rimaniol, A.-C., Poron, F., et al. (2003). Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J. Cell Biol. 163, 1133–1143. doi: 10.1083/jcb.200212046
Collins, K. H., Herzog, W., MacDonald, G. Z., Reimer, R. A., Rios, J. L., Smith, I. C., et al. (2018). Obesity, metabolic syndrome, and musculoskeletal disease: common inflammatory pathways suggest a central role for loss of muscle integrity. Front. Physiol. 9:112. doi: 10.3389/fphys.2018.00112
Conte, M., Martucci, M., Sandri, M., Franceschi, C., and Salvioli, S. (2019). The dual role of the pervasive “fattish” tissue remodeling with age. Front. Endocrinol. 10:114. doi: 10.3389/fendo.2019.00114
Contreras, O., Rebolledo, D. L., Oyarzún, J. E., Olguín, H. C., and Brandan, E. (2016). Connective tissue cells expressing fibro/adipogenic progenitor markers increase under chronic damage: relevance in fibroblast-myofibroblast differentiation and skeletal muscle fibrosis. Cell Tissue Res. 364, 647–660. doi: 10.1007/s00441-015-2343-0
Cordani, N., Pisa, V., Pozzi, L., Sciorati, C., and Clementi, E. (2014). Nitric oxide controls fat deposition in dystrophic skeletal muscle by regulating fibro-adipogenic precursor differentiation. Stem Cells 32, 874–885. doi: 10.1002/stem.1587
Cui, C.-Y., Driscoll, R. K., Piao, Y., Chia, C. W., Gorospe, M., and Ferrucci, L. (2019). Skewed macrophage polarization in aging skeletal muscle. Aging Cell 18:e13032. doi: 10.1111/acel.13032
Cuthbertson, D. J., Steele, T., Wilding, J. P., Halford, J. C., Harrold, J. A., Hamer, M., et al. (2017). What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications? Int. J. Obes. 41, 853–865. doi: 10.1038/ijo.2017.4
Czech, M. P. (2017). Insulin action and resistance in obesity and type 2 diabetes. Nat. Med. 23, 804–814. doi: 10.1038/nm.4350
Dammone, G., Karaz, S., Lukjanenko, L., Winkler, C., Sizzano, F., Jacot, G., et al. (2018). PPARγ controls ectopic adipogenesis and cross-talks with myogenesis during skeletal muscle regeneration. Int. J. Mol. Sci. 19:E2044. doi: 10.3390/ijms19072044
Davies, M. R., Liu, X., Lee, L., Laron, D., Ning, A. Y., Kim, H. T., et al. (2016). TGF-β small molecule inhibitor SB431542 reduces rotator cuff muscle fibrosis and fatty infiltration by promoting fibro/adipogenic progenitor apoptosis. PLoS One 11:e0155486. doi: 10.1371/journal.pone.0155486
De Lisio, M., Farup, J., Sukiennik, R. A., Clevenger, N., Nallabelli, J., Nelson, B., et al. (2015). The acute response of pericytes to muscle-damaging eccentric contraction and protein supplementation in human skeletal muscle. J. Appl. Physiol. 119, 900–907. doi: 10.1152/japplphysiol.01112.2014
De Lisio, M., Jensen, T., Sukiennik, R. A., Huntsman, H. D., and Boppart, M. D. (2014). Substrate and strain alter the muscle-derived mesenchymal stem cell secretome to promote myogenesis. Stem Cell Res. Ther. 5:74. doi: 10.1186/scrt463
DeFronzo, R. A., Jacot, E., Jequier, E., Maeder, E., Wahren, J., and Felber, J. P. (1981). The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30, 1000–1007. doi: 10.2337/diab.30.12.1000
Delmonico, M. J., Harris, T. B., Visser, M., Park, S. W., Conroy, M. B., Velasquez-Mieyer, P., et al. (2009). Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am. J. Clin. Nutr. 90, 1579–1585. doi: 10.3945/ajcn.2009.28047
Dong, J., Dong, Y., Chen, Z., Mitch, W. E., and Zhang, L. (2017). The pathway to muscle fibrosis depends on myostatin stimulating the differentiation of fibro/adipogenic progenitor cells in chronic kidney disease. Kidney Int. 91, 119–128. doi: 10.1016/j.kint.2016.07.029
D’Souza, D., Roubos, S., Larkin, J., Lloyd, J., Emmons, R., Chen, H., et al. (2019). The late effects of radiation therapy on skeletal muscle morphology and progenitor cell content are influenced by diet-induced obesity and exercise training in male mice. Sci. Rep. 9:6691. doi: 10.1038/s41598-019-43204-8
D’Souza, D. M., Trajcevski, K. E., Al-Sajee, D., Wang, D. C., Thomas, M., Anderson, J. E., et al. (2015). Diet-induced obesity impairs muscle satellite cell activation and muscle repair through alterations in hepatocyte growth factor signaling. Physiol. Rep. 3:e12506. doi: 10.14814/phy2.12506
Dubé, J. J., Amati, F., Stefanovic-Racic, M., Toledo, F. G. S., Sauers, S. E., and Goodpaster, B. H. (2008). Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete’s paradox revisited. Am. J. Physiol. Endocrinol. Metab. 294, E882–E888. doi: 10.1152/ajpendo.00769.2007
Dvoretskiy, S., Garg, K., Munroe, M., Pincu, Y., Mahmassani, Z. S., Coombs, C., et al. (2019). The impact of skeletal muscle contraction on CD146+Lin- pericytes. Am. J. Physiol. Cell Physiol. 317, C1011–C1024. doi: 10.1152/ajpcell.00156.2019
Egan, B., and Zierath, J. R. (2013). Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab. 17, 162–184. doi: 10.1016/j.cmet.2012.12.012
Emmons, R., Niemiro, G. M., and De Lisio, M. (2017). Hematopoiesis with obesity and exercise: role of the bone marrow niche. Exerc. Immunol. Rev. 23, 82–95.
Emmons, R., Niemiro, G. M., Owolabi, O., and De Lisio, M. (2016). Acute exercise mobilizes hematopoietic stem and progenitor cells and alters the mesenchymal stromal cell secretome. J. Appl. Physiol. 120, 624–632. doi: 10.1152/japplphysiol.00925.2015
Farup, J., De Lisio, M., Rahbek, S. K., Bjerre, J., Vendelbo, M. H., Boppart, M. D., et al. (2015). Pericyte response to contraction mode-specific resistance exercise training in human skeletal muscle. J. Appl. Physiol. 119, 1053–1063. doi: 10.1152/japplphysiol.01108.2014
Febbraio, M. A. (2007). Exercise and inflammation. J. Appl. Physiol. 103, 376–377. doi: 10.1152/japplphysiol.00414.2007
Febbraio, M. A., Hiscock, N., Sacchetti, M., Fischer, C. P., and Pedersen, B. K. (2004). Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes 53, 1643–1648. doi: 10.2337/diabetes.53.7.1643
Feige, P., Brun, C. E., Ritso, M., and Rudnicki, M. A. (2018). Orienting muscle stem cells for regeneration in homeostasis, aging, and disease. Cell Stem Cell 23, 653–664. doi: 10.1016/j.stem.2018.10.006
Fiore, D., Judson, R. N., Low, M., Lee, S., Zhang, E., Hopkins, C., et al. (2016). Pharmacological blockage of fibro/adipogenic progenitor expansion and suppression of regenerative fibrogenesis is associated with impaired skeletal muscle regeneration. Stem Cell Res. 17, 161–169. doi: 10.1016/j.scr.2016.06.007
Goodpaster, B. H., Thaete, F. L., and Kelley, D. E. (2000). Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am. J. Clin. Nutr. 71, 885–892. doi: 10.1093/ajcn/71.4.885
Goodpaster, B. H., Thaete, F. L., Simoneau, J. A., and Kelley, D. E. (1997). Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 46, 1579–1585. doi: 10.2337/diacare.46.10.1579
Gorski, T., Mathes, S., and Krützfeldt, J. (2018). Uncoupling protein 1 expression in adipocytes derived from skeletal muscle fibro/adipogenic progenitors is under genetic and hormonal control. J. Cachexia Sarcopenia Muscle 9, 384–399. doi: 10.1002/jcsm.12277
Goss, A. M., and Gower, B. A. (2012). Insulin sensitivity is associated with thigh adipose tissue distribution in healthy postmenopausal women. Metab. Clin. Exp. 61, 1817–1823. doi: 10.1016/j.metabol.2012.05.016
Hamrick, M. W., McGee-Lawrence, M. E., and Frechette, D. M. (2016). Fatty infiltration of skeletal muscle: mechanisms and comparisons with bone marrow adiposity. Front. Endocrinol. 7:69. doi: 10.3389/fendo.2016.00069
Han, X., Møller, L. L. V., De Groote, E., Bojsen-Møller, K. N., Davey, J., Henríquez-Olguin, C., et al. (2019). Mechanisms involved in follistatin-induced hypertrophy and increased insulin action in skeletal muscle. J. Cachexia Sarcopenia Muscle 10, 1241–1257. doi: 10.1002/jcsm.12474
Heredia, J. E., Mukundan, L., Chen, F. M., Mueller, A. A., Deo, R. C., Locksley, R. M., et al. (2013). Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell 153, 376–388. doi: 10.1016/j.cell.2013.02.053
Hogarth, M. W., Defour, A., Lazarski, C., Gallardo, E., Diaz Manera, J., Partridge, T. A., et al. (2019). Fibroadipogenic progenitors are responsible for muscle loss in limb girdle muscular dystrophy 2B. Nat. Commun. 10:2430. doi: 10.1038/s41467-019-10438-z
Hoy, D., Geere, J.-A., Davatchi, F., Meggitt, B., and Barrero, L. H. (2014). A time for action: opportunities for preventing the growing burden and disability from musculoskeletal conditions in low- and middle-income countries. Best Pract. Res. Clin. Rheumatol. 28, 377–393. doi: 10.1016/j.berh.2014.07.006
Huntsman, H. D., Rendeiro, C., Merritt, J. R., Pincu, Y., Cobert, A., De Lisio, M., et al. (2018). The impact of mechanically stimulated muscle-derived stromal cells on aged skeletal muscle. Exp. Gerontol. 103, 35–46. doi: 10.1016/j.exger.2017.12.012
Huntsman, H. D., Zachwieja, N., Zou, K., Ripchik, P., Valero, M. C., De Lisio, M., et al. (2013). Mesenchymal stem cells contribute to vascular growth in skeletal muscle in response to eccentric exercise. Am. J. Physiol. Heart Circ. Physiol. 304, H72–H81. doi: 10.1152/ajpheart.00541-2012
Ieronimakis, N., Hays, A. L., Janebodin, K., Mahoney, W. M., Duffield, J. S., Majesky, M. W., et al. (2013). Coronary adventitial cells are linked to perivascular cardiac fibrosis via TGFβ1 signaling in the mdx mouse model of Duchenne muscular dystrophy. J. Mol. Cell. Cardiol. 63, 122–134. doi: 10.1016/j.yjmcc.2013.07.014
Ito, T., Ogawa, R., Uezumi, A., Ohtani, T., Watanabe, Y., Tsujikawa, K., et al. (2013). Imatinib attenuates severe mouse dystrophy and inhibits proliferation and fibrosis-marker expression in muscle mesenchymal progenitors. Neuromuscul. Disord. 23, 349–356. doi: 10.1016/j.nmd.2012.10.025
Joe, A. W. B., Yi, L., Natarajan, A., Le Grand, F., So, L., Wang, J., et al. (2010). Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat. Cell Biol. 12, 153–163. doi: 10.1038/ncb2015
Juban, G., Saclier, M., Yacoub-Youssef, H., Kernou, A., Arnold, L., Boisson, C., et al. (2018). AMPK activation regulates LTBP4-dependent TGF-β1 secretion by pro-inflammatory macrophages and controls fibrosis in Duchenne muscular dystrophy. Cell Rep. 25, 2163–2176.e6. doi: 10.1016/j.celrep.2018.10.077
Kang, X., Yang, M.-Y., Shi, Y.-X., Xie, M.-M., Zhu, M., Zheng, X.-L., et al. (2018). Interleukin-15 facilitates muscle regeneration through modulation of fibro/adipogenic progenitors. Cell Commun. Signal. 16:42. doi: 10.1186/s12964-018-0251-0
Kautzky-Willer, A., Krssak, M., Winzer, C., Pacini, G., Tura, A., Farhan, S., et al. (2003). Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes. Diabetes 52, 244–251. doi: 10.2337/diabetes.52.2.244
Khan, I. M., Perrard, X. Y., Brunner, G., Lui, H., Sparks, L. M., Smith, S. R., et al. (2015). Intermuscular and perimuscular fat expansion in obesity correlates with skeletal muscle T cell and macrophage infiltration and insulin resistance. Int. J. Obes. 39, 1607–1618. doi: 10.1038/ijo.2015.104
Kirkland, J. L., Tchkonia, T., Pirtskhalava, T., Han, J., and Karagiannides, I. (2002). Adipogenesis and aging: does aging make fat go MAD? Exp. Gerontol. 37, 757–767. doi: 10.1016/s0531-5565(02)00014-1
Knobloch, M., Pilz, G.-A., Ghesquière, B., Kovacs, W. J., Wegleiter, T., Moore, D. L., et al. (2017). A fatty acid oxidation-dependent metabolic shift regulates adult neural stem cell activity. Cell Rep. 20, 2144–2155. doi: 10.1016/j.celrep.2017.08.029
Kopinke, D., Roberson, E. C., and Reiter, J. F. (2017). Ciliary hedgehog signaling restricts injury-induced adipogenesis. Cell 170, 340–351.e12. doi: 10.1016/j.cell.2017.06.035
Lancaster, G. I., and Febbraio, M. A. (2014). The immunomodulating role of exercise in metabolic disease. Trends Immunol. 35, 262–269. doi: 10.1016/j.it.2014.02.008
Lawler, H. M., Underkofler, C. M., Kern, P. A., Erickson, C., Bredbeck, B., and Rasouli, N. (2016). Adipose tissue hypoxia, inflammation, and fibrosis in obese insulin-sensitive and obese insulin-resistant subjects. J. Clin. Endocrinol. Metab. 101, 1422–1428. doi: 10.1210/jc.2015-4125
Lee, M.-J. (2018). Transforming growth factor beta superfamily regulation of adipose tissue biology in obesity. Biochim. Biophys. Acta Mol. Basis Dis. 1864, 1160–1171. doi: 10.1016/j.bbadis.2018.01.025
Lee, S. J., and McPherron, A. C. (2001). Regulation of myostatin activity and muscle growth. Proc. Natl. Acad. Sci. U.S.A. 98, 9306–9311. doi: 10.1073/pnas.151270098
Lemos, D. R., Babaeijandaghi, F., Low, M., Chang, C.-K., Lee, S. T., Fiore, D., et al. (2015). Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro/adipogenic progenitors. Nat. Med. 21, 786–794. doi: 10.1038/nm.3869
Liu, L., Charville, G. W., Cheung, T. H., Yoo, B., Santos, P. J., Schroeder, M., et al. (2018). Impaired notch signaling leads to a decrease in p53 activity and mitotic catastrophe in aged muscle stem cells. Cell Stem Cell 23, 544–556.e4. doi: 10.1016/j.stem.2018.08.019
Lukjanenko, L., Karaz, S., Stuelsatz, P., Gurriaran-Rodriguez, U., Michaud, J., Dammone, G., et al. (2019). Aging disrupts muscle stem cell function by impairing matricellular WISP1 secretion from fibro-adipogenic progenitors. Cell Stem Cell 24, 433–446.e7. doi: 10.1016/j.stem.2018.12.014
Madaro, L., Passafaro, M., Sala, D., Etxaniz, U., Lugarini, F., Proietti, D., et al. (2018). Denervation-activated STAT3-IL-6 signalling in fibro-adipogenic progenitors promotes myofibres atrophy and fibrosis. Nat. Cell Biol. 20, 917–927. doi: 10.1038/s41556-018-0151-y
Mann, C. J., Perdiguero, E., Kharraz, Y., Aguilar, S., Pessina, P., Serrano, A. L., et al. (2011). Aberrant repair and fibrosis development in skeletal muscle. Skelet. Muscle 1:21. doi: 10.1186/2044-5040-1-21
Manuel, D. G., Tuna, M., Hennessy, D., Bennett, C., Okhmatovskaia, A., Finès, P., et al. (2014). Projections of preventable risks for cardiovascular disease in Canada to 2021: a microsimulation modelling approach. CMAJ Open 2, E94–E101. doi: 10.9778/cmajo.2012-0015
March, L., Smith, E. U. R., Hoy, D. G., Cross, M. J., Sanchez-Riera, L., Blyth, F., et al. (2014). Burden of disability due to musculoskeletal (MSK) disorders. Best Pract. Res. Clin. Rheumatol. 28, 353–366. doi: 10.1016/j.berh.2014.08.002
Marinkovic, M., Fuoco, C., Sacco, F., Cerquone Perpetuini, A., Giuliani, G., Micarelli, E., et al. (2019). Fibro-adipogenic progenitors of dystrophic mice are insensitive to NOTCH regulation of adipogenesis. Life Sci. Alliance 2:e201900437. doi: 10.26508/lsa.201900437
Martinez-Huenchullan, S., McLennan, S. V., Verhoeven, A., Twigg, S. M., and Tam, C. S. (2017). The emerging role of skeletal muscle extracellular matrix remodelling in obesity and exercise. Obes. Rev. 18, 776–790. doi: 10.1111/obr.12548
McKay, B. R., De Lisio, M., Johnston, A. P. W., O’Reilly, C. E., Phillips, S. M., Tarnopolsky, M. A., et al. (2009). Association of interleukin-6 signalling with the muscle stem cell response following muscle-lengthening contractions in humans. PLoS One 4:e6027. doi: 10.1371/journal.pone.0006027
Miljkovic-Gacic, I., Gordon, C. L., Goodpaster, B. H., Bunker, C. H., Patrick, A. L., Kuller, L. H., et al. (2008). Adipose tissue infiltration in skeletal muscle: age patterns and association with diabetes among men of African ancestry. Am. J. Clin. Nutr. 87, 1590–1595. doi: 10.1093/ajcn/87.6.1590
Mogi, M., Kohara, K., Nakaoka, H., Kan-No, H., Tsukuda, K., Wang, X.-L., et al. (2016). Diabetic mice exhibited a peculiar alteration in body composition with exaggerated ectopic fat deposition after muscle injury due to anomalous cell differentiation. J. Cachexia Sarcopenia Muscle 7, 213–224. doi: 10.1002/jcsm.12044
Moratal, C., Raffort, J., Arrighi, N., Rekima, S., Schaub, S., Dechesne, C. A., et al. (2018). IL-1β- and IL-4-polarized macrophages have opposite effects on adipogenesis of intramuscular fibro-adipogenic progenitors in humans. Sci. Rep. 8:17005. doi: 10.1038/s41598-018-35429-w
Mozzetta, C., Consalvi, S., Saccone, V., Tierney, M., Diamantini, A., Mitchell, K. J., et al. (2013). Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice. EMBO Mol. Med. 5, 626–639. doi: 10.1002/emmm.201202096
Mueller, A. A., van Velthoven, C. T., Fukumoto, K. D., Cheung, T. H., and Rando, T. A. (2016). Intronic polyadenylation of PDGFRα in resident stem cells attenuates muscle fibrosis. Nature 540, 276–279. doi: 10.1038/nature20160
Munir, H., Ward, L. S. C., and McGettrick, H. M. (2018). Mesenchymal stem cells as endogenous regulators of inflammation. Adv. Exp. Med. Biol. 1060, 73–98. doi: 10.1007/978-3-319-78127-3_5
Murphy, M. M., Lawson, J. A., Mathew, S. J., Hutcheson, D. A., and Kardon, G. (2011). Satellite cells, connective tissue fibroblasts and their interactions are crucial for muscle regeneration. Development 138, 3625–3637. doi: 10.1242/dev.064162
Nielsen, A. R., and Pedersen, B. K. (2007). The biological roles of exercise-induced cytokines: IL-6, IL-8, and IL-15. Appl. Physiol. Nutr. Metab. 32, 833–839. doi: 10.1139/H07-054
Ostrowski, K., Hermann, C., Bangash, A., Schjerling, P., Nielsen, J. N., and Pedersen, B. K. (1998). A trauma-like elevation of plasma cytokines in humans in response to treadmill running. J. Physiol. 513(Pt 3), 889–894. doi: 10.1111/j.1469-7793.1998.889ba.x
Pagano, A. F., Arc-Chagnaud, C., Brioche, T., Chopard, A., and Py, G. (2019). Muscle resting and TGF-β inhibitor treatment prevent fatty infiltration following skeletal muscle injury. Cell. Physiol. Biochem. 53, 62–75. doi: 10.33594/000000121
Pala, F., Di Girolamo, D., Mella, S., Yennek, S., Chatre, L., Ricchetti, M., et al. (2018). Distinct metabolic states govern skeletal muscle stem cell fates during prenatal and postnatal myogenesis. J. Cell Sci. 131:jcs212977. doi: 10.1242/jcs.212977
Paulsen, G., Crameri, R., Benestad, H. B., Fjeld, J. G., Mørkrid, L., Hallén, J., et al. (2010). Time course of leukocyte accumulation in human muscle after eccentric exercise. Med. Sci. Sports Exerc. 42, 75–85. doi: 10.1249/MSS.0b013e3181ac7adb
Pedersen, B. K., and Steensberg, A. (2002). Exercise and hypoxia: effects on leukocytes and interleukin-6-shared mechanisms? Med. Sci. Sports Exerc. 34, 2004–2013. doi: 10.1097/00005768-200212000-00022
Ran, C., Liu, H., Hitoshi, Y., and Israel, M. A. (2013). Proliferation-independent control of tumor glycolysis by PDGFR-mediated AKT activation. Cancer Res. 73, 1831–1843. doi: 10.1158/0008-5472.CAN-12-2460
Reggio, A., Rosina, M., Krahmer, N., Petrilli, L. L., Maiolatesi, G., Massacci, G., et al. (2019). Metabolic Reprogramming of Fibro/Adipogenic Progenitors Facilitates Muscle Regeneration. Rochester, NY: Social Science Research Network.
Rodeheffer, M. S. (2010). Tipping the scale: muscle versus fat. Nat. Cell Biol. 12, 102–104. doi: 10.1038/ncb0210-102
Rodgers, J. T., King, K. Y., Brett, J. O., Cromie, M. J., Charville, G. W., Maguire, K. K., et al. (2014). mTORC1 controls the adaptive transition of quiescent stem cells from G0 to G(Alert). Nature 510, 393–396. doi: 10.1038/nature13255
Rostasy, K. M., Schmidt, J., Bahn, E., Pfander, T., Piepkorn, M., Wilichowski, E., et al. (2008). Distinct inflammatory properties of late-activated macrophages in inflammatory myopathies. Acta Myol. 27, 49–53.
Rubin, J., Styner, M., and Uzer, G. (2018). Physical signals may affect mesenchymal stem cell differentiation via epigenetic controls. Exerc. Sport Sci. Rev. 46, 42–47. doi: 10.1249/JES.0000000000000129
Ryall, J. G., Cliff, T., Dalton, S., and Sartorelli, V. (2015a). Metabolic reprogramming of stem cell epigenetics. Cell Stem Cell 17, 651–662. doi: 10.1016/j.stem.2015.11.012
Ryall, J. G., Dell’Orso, S., Derfoul, A., Juan, A., Zare, H., Feng, X., et al. (2015b). The NAD(+)-dependent SIRT1 deacetylase translates a metabolic switch into regulatory epigenetics in skeletal muscle stem cells. Cell Stem Cell 16, 171–183. doi: 10.1016/j.stem.2014.12.004
Ryan, A. S., and Nicklas, B. J. (1999). Age-related changes in fat deposition in mid-thigh muscle in women: relationships with metabolic cardiovascular disease risk factors. Int. J. Obes. Relat. Metab. Disord. 23, 126–132. doi: 10.1038/sj.ijo.0800777
Sachs, S., Zarini, S., Kahn, D. E., Harrison, K. A., Perreault, L., Phang, T., et al. (2019). Intermuscular adipose tissue directly modulates skeletal muscle insulin sensitivity in humans. Am. J. Physiol. Endocrinol. Metab. 316, E866–E879. doi: 10.1152/ajpendo.00243.2018
Saklayen, M. G. (2018). The global epidemic of the metabolic syndrome. Curr. Hypertens. Rep. 20:12. doi: 10.1007/s11906-018-0812-z
Sakuma, K., and Yamaguchi, A. (2013). Sarcopenic obesity and endocrinal adaptation with age. Int. J. Endocrinol. 2013:204164. doi: 10.1155/2013/204164
Samjoo, I. A., Safdar, A., Hamadeh, M. J., Glover, A. W., Mocellin, N. J., Santana, J., et al. (2013). Markers of skeletal muscle mitochondrial function and lipid accumulation are moderately associated with the homeostasis model assessment index of insulin resistance in obese men. PLoS One 8:e66322. doi: 10.1371/journal.pone.0066322
Serrano, A. L., Baeza-Raja, B., Perdiguero, E., Jardí, M., and Muñoz-Cánoves, P. (2008). Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab. 7, 33–44. doi: 10.1016/j.cmet.2007.11.011
Shyh-Chang, N., Daley, G. Q., and Cantley, L. C. (2013). Stem cell metabolism in tissue development and aging. Development 140, 2535–2547. doi: 10.1242/dev.091777
Sinha, R., Dufour, S., Petersen, K. F., LeBon, V., Enoksson, S., Ma, Y.-Z., et al. (2002). Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes 51, 1022–1027. doi: 10.2337/diabetes.51.4.1022
Stumm, J., Vallecillo-García, P., Vom Hofe-Schneider, S., Ollitrault, D., Schrewe, H., Economides, A. N., et al. (2018). Odd skipped-related 1 (Osr1) identifies muscle-interstitial fibro-adipogenic progenitors (FAPs) activated by acute injury. Stem Cell Res. 32, 8–16. doi: 10.1016/j.scr.2018.08.010
Szendroedi, J., Yoshimura, T., Phielix, E., Koliaki, C., Marcucci, M., Zhang, D., et al. (2014). Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans. Proc. Natl. Acad. Sci. U.S.A. 111, 9597–9602. doi: 10.1073/pnas.1409229111
Tang, A. H., and Rando, T. A. (2014). Induction of autophagy supports the bioenergetic demands of quiescent muscle stem cell activation. EMBO J. 33, 2782–2797. doi: 10.15252/embj.201488278
Tidball, J. G. (2011). Mechanisms of muscle injury, repair, and regeneration. Compr. Physiol. 1, 2029–2062. doi: 10.1002/cphy.c100092
Tidball, J. G. (2017). Regulation of muscle growth and regeneration by the immune system. Nat. Rev. Immunol. 17, 165–178. doi: 10.1038/nri.2016.150
Uezumi, A., Fukada, S., Yamamoto, N., Ikemoto-Uezumi, M., Nakatani, M., Morita, M., et al. (2014). Identification and characterization of PDGFRα+ mesenchymal progenitors in human skeletal muscle. Cell Death Dis. 5:e1186. doi: 10.1038/cddis.2014.161
Uezumi, A., Fukada, S., Yamamoto, N., Takeda, S., and Tsuchida, K. (2010). Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat. Cell Biol. 12, 143–152. doi: 10.1038/ncb2014
Uezumi, A., Ito, T., Morikawa, D., Shimizu, N., Yoneda, T., Segawa, M., et al. (2011). Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle. J. Cell Sci. 124, 3654–3664. doi: 10.1242/jcs.086629
Valero, M. C., Huntsman, H. D., Liu, J., Zou, K., and Boppart, M. D. (2012). Eccentric exercise facilitates mesenchymal stem cell appearance in skeletal muscle. PLoS One 7:e29760. doi: 10.1371/journal.pone.0029760
Van Linthout, S., Miteva, K., and Tschöpe, C. (2014). Crosstalk between fibroblasts and inflammatory cells. Cardiovasc. Res. 102, 258–269. doi: 10.1093/cvr/cvu062
van Loon, L. J. C., Koopman, R., Manders, R., van der Weegen, W., van Kranenburg, G. P., and Keizer, H. A. (2004). Intramyocellular lipid content in type 2 diabetes patients compared with overweight sedentary men and highly trained endurance athletes. Am. J. Physiol. Endocrinol. Metab. 287, E558–E565. doi: 10.1152/ajpendo.00464.2003
Vincent, A. E., Rosa, H. S., Alston, C. L., Grady, J. P., Rygiel, K. A., Rocha, M. C., et al. (2016). Dysferlin mutations and mitochondrial dysfunction. Neuromuscul. Disord. 26, 782–788. doi: 10.1016/j.nmd.2016.08.008
Visser, M., Goodpaster, B. H., Kritchevsky, S. B., Newman, A. B., Nevitt, M., Rubin, S. M., et al. (2005). Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J. Gerontol. A Biol. Sci. Med. Sci. 60, 324–333. doi: 10.1093/gerona/60.3.324
Walton, R. G., Kosmac, K., Mula, J., Fry, C. S., Peck, B. D., Groshong, J. S., et al. (2019). Human skeletal muscle macrophages increase following cycle training and are associated with adaptations that may facilitate growth. Sci. Rep. 9:969. doi: 10.1038/s41598-018-37187-1
Wang, Y., Wehling-Henricks, M., Samengo, G., and Tidball, J. G. (2015). Increases of M2a macrophages and fibrosis in aging muscle are influenced by bone marrow aging and negatively regulated by muscle-derived nitric oxide. Aging Cell 14, 678–688. doi: 10.1111/acel.12350
Wang, Y. X., and Rudnicki, M. A. (2011). Satellite cells, the engines of muscle repair. Nat. Rev. Mol. Cell Biol. 13, 127–133. doi: 10.1038/nrm3265
Wearing, S. C., Hennig, E. M., Byrne, N. M., Steele, J. R., and Hills, A. P. (2006). Musculoskeletal disorders associated with obesity: a biomechanical perspective. Obes. Rev. 7, 239–250. doi: 10.1111/j.1467-789X.2006.00251.x
WHO (2019). Overweight and Obesity. Available at: https://www.who.int/gho/ncd/risk_factors/overweight/en/ (accessed October 31, 2019).
Wosczyna, M. N., Konishi, C. T., Perez Carbajal, E. E., Wang, T. T., Walsh, R. A., Gan, Q., et al. (2019). Mesenchymal stromal cells are required for regeneration and homeostatic maintenance of skeletal muscle. Cell Rep. 27, 2029–2035.e5. doi: 10.1016/j.celrep.2019.04.074
Xiao, Y., Peng, H., Hong, C., Chen, Z., Deng, X., Wang, A., et al. (2017). PDGF promotes the Warburg effect in pulmonary arterial smooth muscle cells via activation of the PI3K/AKT/mTOR/HIF-1α signaling pathway. Cell. Physiol. Biochem. 42, 1603–1613. doi: 10.1159/000479401
Zeve, D., Millay, D. P., Seo, J., and Graff, J. M. (2016). Exercise-induced skeletal muscle adaptations alter the activity of adipose progenitor cells. PLoS One 11:e0152129. doi: 10.1371/journal.pone.0152129
Zhao, X., Kwan, J. Y. Y., Yip, K., Liu, P. P., and Liu, F.-F. (2019). Targeting metabolic dysregulation for fibrosis therapy. Nat. Rev. Drug Discov. 19, 57–75. doi: 10.1038/s41573-019-0040-5
Zhu, S., Tian, Z., Torigoe, D., Zhao, J., Xie, P., Sugizaki, T., et al. (2019). Aging- and obesity-related peri-muscular adipose tissue accelerates muscle atrophy. PLoS One 14:e0221366. doi: 10.1371/journal.pone.0221366
Zou, K., Huntsman, H. D., Carmen Valero, M., Adams, J., Skelton, J., De Lisio, M., et al. (2015). Mesenchymal stem cells augment the adaptive response to eccentric exercise. Med. Sci. Sports Exerc. 47, 315–325. doi: 10.1249/MSS.0000000000000405
Keywords: obesity, metabolic syndrome, FAPs, differentiation, skeletal muscle, physical activity, exercise, mesenchymal stem cell
Citation: Collao N, Farup J and De Lisio M (2020) Role of Metabolic Stress and Exercise in Regulating Fibro/Adipogenic Progenitors. Front. Cell Dev. Biol. 8:9. doi: 10.3389/fcell.2020.00009
Received: 01 November 2019; Accepted: 10 January 2020;
Published: 28 January 2020.
Edited by:
Anthony Scimè, York University, CanadaReviewed by:
Robert Neil Judson, StemCell Technologies Inc., CanadaLuca Madaro, Santa Lucia Foundation (IRCCS), Italy
Valentina Saccone, Santa Lucia Foundation (IRCCS), Italy
Copyright © 2020 Collao, Farup and De Lisio. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Michael De Lisio, mdelisio@uottawa.ca